NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









LinusBio

LinusBio

Private
New JerseyHealthcare & Life Scienceshttps://www.linusbio.com/

Last Round

VC Round

Jun 16, 2025

Est. Valuation

$170M

Total Funding Raised

$24M

Company Overview

LinusBio is a biotechnology company that provides a precision exposome medicine platform to analyze the molecular impact of environmental exposures on health, with applications in diagnosing and treating complex disorders.

Sector

Healthcare & Life Sciences

Verticals

Precision Medicine, Biotechnology, Healthcare Analytics, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Usage-Based SaaS

AI Layer

Application

Keywords

precision medicineexposome sequencingdiagnostic platformbiomarker discoveryautism spectrum disorderASDclinical diagnosticsmolecular diagnosticsCLIA laboratoryneurodevelopmental disordersAI diagnosticsdigital biomarkersclinical trial supporthealth techbiotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

LinusBio Comparables

Compare LinusBio with similar companies based on industry and business-model similarity.

LinusBio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
MARAbio
81%
NeuroQure
78%
EarliPoint Health
74%

LinusBio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundJun 16, 2025
VC RoundAug 12, 2024
Series A ExtensionMay 31, 2023
Series AJan 12, 2023

Key People

Founding team and executive leadership

David Bellet

Advisor To Linus Bio CEO

Executive Team

Manish Arora

Founder And CEO

Founding Team

Victoria Polyanskaya

Chief Operating Officer

Executive Team

LinusBio Investors

Notable investors and investment history

LinusBio investors
InvestorRounds
GreatPoint VenturesSeries A
GreatPoint VenturesSeries A
Bow CapitalSeries A Extension, Series A
Divergent InvestmentsSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 5, 2025

    Partnered with Coralis Health to advance autism detection.

  • Jun 16, 2025

    $3M raised in a VC Round.

LinusBio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

LinusBio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about LinusBio's valuation, stock price, and market status.

Firmographic Details

HeadquartersNew Jersey
Employee Range33
Year Founded2020
Last FundingJun 16, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.